Sfoglia per Autore
TP53, P14ARF, P16INK4a and H-ras gene molecular analysis in intestinal-type adenocarcinoma of the nasal cavity and paranasal sinuses
2003 F. Perrone, M. Oggionni, S. Birindelli, S. Suardi, S. Tabano, R. Romano, M.L. Moiraghi, G. Bimbi, P. Quattrone, G. Cantu, M.A. Pierotti, L. Licitra, S. Pilotti
Molecular and cytogenetic subgroups of oropharyngeal squamous cell carcinoma
2006 F. Perrone, S. Suardi, E. Pastore, P. Casieri, M. Orsenigo, S. Caramuta, G. Dagrada, M. Losa, L. Licitra, P. Bossi, S. Staurengo, M. Oggionni, L. Locati, G. Cantu, M. Squadrelli, A. Carbone, M.A. Pierotti, S. Pilotti
TP53 mutations in head and neck cancer
2008 F.P. Perrone, P. Bossi, L.F.L. Licitra
Cetuximab in recurrent and/or metastatic salivary gland carcinomas: A phase II study
2009 L. L. D., B. P., F.P. Perrone, P. P., C. F., M. L., C. P., M.N. Orsenigo, L. M., B. C., C. Liberatoscioli, Q. P., R.G. Calderone, S.G. Rinaldi, P. S., L.F.L. Licitra
Treatment relevant target immunophenotyping of 139 salivary gland carcinomas (SGCs)
2009 L.D. Locati, F. Perrone, M. Losa, M. Mela, P. Casieri, M. Orsenigo, B. Cortelazzi, T. Negri, E. Tamborini, P. Quattrone, P. Bossi, G. Rinaldi, C. Bergamini, R.G. Calderone, C. Liberatoscioli, L. Licitra
Oropharyngeal Squamous Cell Carcinoma Treated With Radiotherapy or Radiochemotherapy: Prognostic Role of TP53 and HPV Status
2009 C. Fallai, F. Perrone, L. Licitra, S. Pilotti, L. Locati, P. Bossi, E. Orlandi, M. Palazzi, P. Olmi
TP53 mutations and pathologic complete response to neoadjuvant cisplatin and fluorouracil chemotherapy in resected oral cavity squamous cell carcinoma
2010 F. Perrone, P. Bossi, B. Cortelazzi, L. Locati, P. Quattrone, M..A. Pierotti, S. Pilotti, L. Licitra
Role of EGFR family receptors in proliferation of squamous carcinoma cells induced by wound healing fluids of head and neck cancer patients
2011 L. Licitra, F. Perrone, E. Tamborini, L. Bertola, C. Ghirelli, T. Negri, M. Orsenigo, P. Filipazzi, E. Pastore, M. Pompilio, P. Bossi, L.D. Locati, G. Cantu', G. Scaramellini, S. Pilotti, E. Tagliabue
Isolating p16-positive/HPV-negative Oropharyngeal Cancer : An Effort Worth Making
2011 F. Perrone, A. Gloghini, B. Cortelazzi, P. Bossi, L. Licitra, S. Pilotti
Prolonged response using gefitinib followed by sirolimus for advanced cutaneous squamous cell carcinoma
2012 P. Bossi, C. Resteghini, F. Perrone, B. Cortelazzi, S. Pilotti, A. Maurichi, L.D. Locati, L. Licitra
Tumor stage, human papillomavirus and smoking status affect the survival of patients with oropharyngeal cancer : An Italian validation study
2012 R. Granata, R. Miceli, E. Orlandi, F. Perrone, B. Cortelazzi, M. Franceschini, L.D. Locati, P. Bossi, C. Bergamini, A. Mirabile, L. Mariani, P. Olmi, G. Scaramellini, P. Potepan, P. Quattrone, K.K. Ang, L. Licitra
Tp53 status as guide for the management of ethmoid sinus intestinal-type adenocarcinoma
2013 P. Bossi, F. Perrone, R. Miceli, G. Cantù, L. Mariani, E. Orlandi, C. Fallai, L.D. Locati, B. Cortelazzi, P. Quattrone, P. Potepan, L. Licitra, S. Pilotti
Treatment-related outcome of oropharyngeal cancer patients differentiated by HPV dictated risk profile: A Tertiary Cancer Centre series analysis
2014 P. Bossi, E. Orlandi, R. Miceli, F. Perrone, M. Guzzo, L. Mariani, R. Granata, L. Locati, C. Fallai, B. Cortelazzi, S. Pilotti, G. Scaramellini, A. Gloghini, L. Licitra
Activity of temozolomide in patients with advanced chemorefractory colorectal cancer and MGMT promoter methylation
2014 F. Pietrantonio, F. Perrone, F. De Braud, A. Castano, C. Maggi, I. Bossi, A. Gevorgyan, P. Biondani, M. Pacifici, A. Busico, M. Gariboldi, F. Festinese, E. Tamborini, M. Di Bartolomeo
Smoothened (SMO) receptor mutations dictate resistance tovismodegib in basal cell carcinoma
2015 S. Pricl, B. Cortelazzi, V. Dal Col, D. Marson, E. Laurini, M. Fermeglia, L. Licitra, S. Pilotti, P. Bossi, F. Perrone
Evolutionary action score of TP53 coding variants is predictive of platinum response in head and neck cancer patients
2015 A.A. Osman, D.M. Neskey, P. Katsonis, A.A. Patel, A.M. Ward, T. Hsu, S.C. Hicks, T.O. Mcdonald, T.J. Ow, M.O. Alves, C.R. Pickering, H.D. Skinner, M. Zhao, E.M. Sturgis, M.S. Kies, A. El Naggar, F. Perrone, L. Licitra, P. Bossi, M. Kimme, M.J. Frederick, O. Lichtarge, J.N. Myers
Absence of ALK and MET alterations in head and neck sarcomatoid carcinoma
2016 F. Perrone, P. Bossi, B. Cortelazzi, G.P. Dagrada, N. Paielli, L. Licitra, S. Pilotti
Prognostic and predictive value of EGFR in head and neck squamous cell carcinoma
2016 P. Bossi, C. Resteghini, N. Paielli, L. Licitra, S. Pilotti, F. Perrone
Functional genomics uncover the biology behind the responsiveness of head and neck squamous cell cancer patients to cetuximab
2016 P. Bossi, C. Bergamini, M. Siano, M.C. Rocca, A.P. Sponghini, F. Favales, M. Giannoccaro, E. Marchesi, B. Cortelazzi, F. Perrone, S. Pilotti, L.D. Locati, L. Licitra, S. Canevari, L. De Cecco
Toward the molecular dissection of peritoneal pseudomyxoma
2016 F. Pietrantonio, F. Perrone, A. Mennitto, E.M. Gleeson, M. Milione, E. Tamborini, A. Busico, G. Settanni, R. Berenato, M. Caporale, F. Morano, I. Bossi, A. Pellegrinelli, M. Di Bartolomeo, F. de Braud, D. Baratti, W.B. Bowne, S. Kusamura, M. Deraco
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile